Stay updated on Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:43:19.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-17T02:17:54.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:48:51.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated: v3.4.2 was removed and v3.4.3 was added to the page.
    Difference
    0.0%
    Check dated 2026-03-12T03:30:28.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page shows a new site revision, v3.4.2, and the prior funding-status notice (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:54:39.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding and the NIH Clinical Center's operating status was added, and the page revision was updated to v3.4.1, while the core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:44:30.000Z thumbnail image

Stay in the know with updates to Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Tumor Infiltrating Lymphocytes Clinical Trial page.